Zhejiang Yatai Pharmaceutical Co Ltd Strategic Asset Allocation Index
Zhejiang Yatai Pharmaceutical Co Ltd strategic asset allocation index. Zhejiang Yatai Pharmaceutical Co Ltd (002370) has a Strategic Asset Allocation Index of 87.9% as of September 2023. Strategic assets (PP&E of CN¥363.29 Million plus long-term investments of CN¥-) total CN¥363.29 Million, measured against net assets of CN¥413.13 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See net asset quality index of Zhejiang Yatai Pharmaceutical Co Ltd to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Zhejiang Yatai Pharmaceutical Co Ltd (2009–2022)
Strategic asset allocation index of Zhejiang Yatai Pharmaceutical Co Ltd from 2009 to 2022. This chart shows how Zhejiang Yatai Pharmaceutical Co Ltd's Strategic Asset Allocation Index has evolved across 14 annual periods from 2009 to 2022. As of September 2023, the index stands at 87.9%, representing strategic assets of CN¥363.29 Million against net assets of CN¥413.13 Million CNY. Check Zhejiang Yatai Pharmaceutical Co Ltd tangible equity quality to evaluate the tangible quality of the company's equity base.
Zhejiang Yatai Pharmaceutical Co Ltd Strategic Asset Allocation Index by Year (2009–2022)
Zhejiang Yatai Pharmaceutical Co Ltd strategic asset allocation index by year from 2009 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Zhejiang Yatai Pharmaceutical Co Ltd from 2009 to 2022, covering 14 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 002370 market cap.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 128.1% | CN¥385.89 Million | CN¥385.89 Million | CN¥- | CN¥301.22 Million | ▲ +27.9 pp |
| 2021 | 100.2% | CN¥433.99 Million | CN¥433.99 Million | CN¥- | CN¥432.96 Million | ▲ +26.4 pp |
| 2020 | 73.9% | CN¥487.75 Million | CN¥487.75 Million | CN¥- | CN¥660.41 Million | ▼ -32.9 pp |
| 2019 | 106.8% | CN¥675.80 Million | CN¥595.93 Million | CN¥79.87 Million | CN¥633.06 Million | ▲ +69.7 pp |
| 2018 | 37.0% | CN¥879.71 Million | CN¥845.86 Million | CN¥33.85 Million | CN¥2.38 Billion | ▲ +9.3 pp |
| 2017 | 27.7% | CN¥631.30 Million | CN¥596.46 Million | CN¥34.84 Million | CN¥2.28 Billion | ▲ +10.8 pp |
| 2016 | 17.0% | CN¥367.34 Million | CN¥341.28 Million | CN¥26.06 Million | CN¥2.17 Billion | ▼ -23.0 pp |
| 2015 | 39.9% | CN¥316.68 Million | CN¥298.01 Million | CN¥18.67 Million | CN¥793.15 Million | ▲ +1.1 pp |
| 2014 | 38.9% | CN¥290.49 Million | CN¥290.49 Million | CN¥- | CN¥747.31 Million | ▼ -0.8 pp |
| 2013 | 39.7% | CN¥281.49 Million | CN¥281.49 Million | CN¥- | CN¥709.83 Million | ▼ -0.9 pp |
| 2012 | 40.6% | CN¥285.82 Million | CN¥285.82 Million | CN¥- | CN¥703.94 Million | ▲ +4.0 pp |
| 2011 | 36.6% | CN¥272.56 Million | CN¥272.56 Million | CN¥- | CN¥745.30 Million | ▲ +1.8 pp |
| 2010 | 34.7% | CN¥250.13 Million | CN¥250.13 Million | CN¥- | CN¥719.95 Million | ▼ -47.0 pp |
| 2009 | 81.8% | CN¥187.95 Million | CN¥187.95 Million | CN¥- | CN¥229.79 Million | — |